Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
846.1000 -6.65 (-0.78%)
NSE Sep 08, 2025 15:31 PM
Volume: 349.1K
 

logo
Natco Pharma Ltd.
24 Aug 2018
846.10
-0.78%
Geojit Research
NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q1FY19 revenue grew by 28% YoY due to stronger performance from domestic (4% vs -20%)) and international formulations(~75%). EBITDA rose by 82% YoY while margin witnessed a 1320bps increase on account of lower raw material cost (RM). PAT growth of 94% YoY is led by lower cost escalations and less...
Number of FII/FPI investors decreased from 385 to 317 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended